Growth Analyser Growth Analyser

Compare funds

Pick up to 10 funds. Compare funds from the same category for a fair reading.

Nippon India Nifty Pharma ETF · Direct ✕HDFC FTSE India Equity ETF · Direct ✕

Growth of ₹10,000

Basics

Nippon India Nifty Pharma ETFHDFC FTSE India Equity ETF
CategoryEquity ETFsEquity ETFs
PlanDirectDirect
Fund houseNippon IndiaHDFC
NAV₹29.1863₹33.7259
NAV date20 Nov 202620 Nov 2026
History5.4 years1 months
Expense ratio0.2%0.0%
StarsNot ratedNot rated
Growth Score——

Returns

Nippon India Nifty Pharma ETFHDFC FTSE India Equity ETF
1 month+10.82%+9.53%
3 months+7.43%—
6 months+14.54%—
YTD+25.40%—
1 year+25.57%—
3 years (CAGR)+22.02%—
5 years (CAGR)+16.60%—
10 years (CAGR)——
Since launch+14.02%+11.18%

Risk

Nippon India Nifty Pharma ETFHDFC FTSE India Equity ETF
Volatility15.0%—
Downside volatility9.0%—
Sharpe1.04—
Sortino1.72—
Calmar1.33—
Return / risk1.47—
Deepest fall−20.98%−3.48%
Days to recover13610
Below its high−1.75%+0.00%

Against benchmark

Nippon India Nifty Pharma ETFHDFC FTSE India Equity ETF
Alpha+0.00%—
Beta1.00—
R²100.0%—
Up capture100.0%—
Down capture100.0%—
Tracking error0.0%—
Information ratio——
Treynor0.14—

Consistency

Nippon India Nifty Pharma ETFHDFC FTSE India Equity ETF
Best 1-year+65.21%—
Middle 1-year+13.46%—
Worst 1-year−15.30%—
1-year periods with a loss25.8%—
Middle 3-year+20.51%—
Positive months61.1%—
Best day+3.64%—
Worst day−4.03%—
Worst 5% day−1.62%—
Positive days54.4%—
NAVs a year248—

SIP of ₹10,000 a month

Nippon India Nifty Pharma ETFHDFC FTSE India Equity ETF
5-year XIRR+20.60%—
5-year value₹10,11,738—
3-year XIRR+19.58%—
1-year XIRR+34.31%—

Holdings overlap i

Overlap needs the monthly portfolio filing of at least two of these funds; not loaded yet.

Search Growth